Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
12-0-TETRADECANOYLPHORBOL 13-ACETATE (TPA)-INDUCED ENZYMATIC CHANGE OF HUMAN NON-T, NON-B LYMPHOID LEUKEMIA-CELL LINES
Authors: SASAKI R KUBONISHI I MINOWADA J BOLLUM FJ MIURA Y TAKAKU F
Citation: R. Sasaki et al., 12-0-TETRADECANOYLPHORBOL 13-ACETATE (TPA)-INDUCED ENZYMATIC CHANGE OF HUMAN NON-T, NON-B LYMPHOID LEUKEMIA-CELL LINES, Haematologia, 25(2), 1993, pp. 111-121
5-YEAR FOLLOW-UP OF DOUBLE-BLIND TEST FOR ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION - EFFECTIVENESS OF HUMAN URINARY M-CSF FOR DISEASE-FREE SURVIVAL AFTER BMT
Authors: HIRAOKA A MASAOKA T SHIBATA H OHNO R KATOH S HARADA M MOTOYOSHI K TAKAKU F SAKUMA A
Citation: A. Hiraoka et al., 5-YEAR FOLLOW-UP OF DOUBLE-BLIND TEST FOR ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION - EFFECTIVENESS OF HUMAN URINARY M-CSF FOR DISEASE-FREE SURVIVAL AFTER BMT, Experimental hematology, 24(9), 1996, pp. 654-654
5 YEARS FOLLOW-UP OF A RANDOMIZED PLACEBO-CONTROLLED STUDY WITH FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: HIRAOAKA A MASAOKA T SHIBATA H KASAI M MORIYAMA Y KATO S KODERA Y MATSUYAMA T HIRABAYASHI N KANAMARU A DOHY H SHIMOSAKA A TAKAKU F
Citation: A. Hiraoaka et al., 5 YEARS FOLLOW-UP OF A RANDOMIZED PLACEBO-CONTROLLED STUDY WITH FILGRASTIM (RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 874-874
ACTIVATION AND PRIMING OF HUMAN MONOCYTES BY MONOCYTE CHEMOTACTIC ANDACTIVATING FACTOR - COOPERATION WITH OTHER INFLAMMATORY CYTOKINES ANDCLOSE ASSOCIATION BETWEEN AN INCREASE IN CYTOPLASMIC FREE CA2+ AND INTRACELLULAR ACIDIFICATION
Authors: AZUMA EK YUO A MATSUSHIMA K KASAHARA T MIZOGUCHI H SAITO M TAKAKU F KITAGAWA S
Citation: Ek. Azuma et al., ACTIVATION AND PRIMING OF HUMAN MONOCYTES BY MONOCYTE CHEMOTACTIC ANDACTIVATING FACTOR - COOPERATION WITH OTHER INFLAMMATORY CYTOKINES ANDCLOSE ASSOCIATION BETWEEN AN INCREASE IN CYTOPLASMIC FREE CA2+ AND INTRACELLULAR ACIDIFICATION, Experimental hematology, 24(2), 1996, pp. 169-175
ACTIVATION OF HUMAN MONOCYTE FUNCTIONS BY TUMOR-NECROSIS-FACTOR - RAPID PRIMING FOR ENHANCED RELEASE OF SUPEROXIDE AND ERYTHROPHAGOCYTOSIS,BUT NO DIRECT TRIGGERING OF SUPEROXIDE RELEASE
Authors: KITAGAWA S YUO A YAGISAWA M AZUMA E YOSHIDA M FURUKAWA Y TAKAHASHI M MASUYAMA J TAKAKU F
Citation: S. Kitagawa et al., ACTIVATION OF HUMAN MONOCYTE FUNCTIONS BY TUMOR-NECROSIS-FACTOR - RAPID PRIMING FOR ENHANCED RELEASE OF SUPEROXIDE AND ERYTHROPHAGOCYTOSIS,BUT NO DIRECT TRIGGERING OF SUPEROXIDE RELEASE, Experimental hematology, 24(4), 1996, pp. 559-567
ACTIVATION OF THE RESPIRATORY BURST AND TYROSINE PHOSPHORYLATION OF PROTEINS IN HUMAN NEUTROPHILS - NO DIRECT RELATIONSHIP AND INVOLVEMENT OF PROTEIN-KINASE C-DEPENDENT AND C-INDEPENDENT SIGNALING PATHWAYS
Authors: AZUMA EK KITAGAWA S YUO A MIZOGUCHI H UMEZAWA K TAKAKU F SAITO M
Citation: Ek. Azuma et al., ACTIVATION OF THE RESPIRATORY BURST AND TYROSINE PHOSPHORYLATION OF PROTEINS IN HUMAN NEUTROPHILS - NO DIRECT RELATIONSHIP AND INVOLVEMENT OF PROTEIN-KINASE C-DEPENDENT AND C-INDEPENDENT SIGNALING PATHWAYS, Biochimica et biophysica acta, 1179(2), 1993, pp. 213-223
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (ALLO-PBSCT) FOR STANDARD-RISK LEUKEMIA
Authors: HARADA M KAWANO F KASAI M SAWADA H NAKAO S OGAWA M TAKAKU F
Citation: M. Harada et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (ALLO-PBSCT) FOR STANDARD-RISK LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 213-213
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR STANDARD-RISK LEUKEMIA - A MULTICENTER PILOT-STUDY - JAPANESE EXPERIENCE
Authors: HARADA M SHINAGAWA K KAWANO T KASAI M SAWADA H NAKAO S HYODO H AOTSUKA N FURUKAWA T HIRAI H ETO T IMAI Y SHIMAZAKI C MATSUE K OGAWA M TAKAKU F
Citation: M. Harada et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR STANDARD-RISK LEUKEMIA - A MULTICENTER PILOT-STUDY - JAPANESE EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 54-56
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR TREATMENT OF STANDARD-RISK LEUKEMIA - MULTICENTER PILOT-STUDY
Authors: HARADA M KAWANO F KIYOKAWA T KASAI M SAWADA H NAKAO S HYODO H SHINAGAWA K OGAWA M TAKAKU F
Citation: M. Harada et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR TREATMENT OF STANDARD-RISK LEUKEMIA - MULTICENTER PILOT-STUDY, Blood, 90(10), 1997, pp. 4493-4493
ANALYSIS OF 313 TRANSPLANTATIONS FROM UNRELATED DONORS FACILITATED BYJAPAN MARROW DONOR PROGRAM
Authors: KODERA Y MORISHIMA Y KATO S HARADA M DOHI H OKAMOTO S IMAMURA H TSUCHIYA S MORIYAMA Y KODO H TSUCHIDA H HOSHI T SHIOBARA S HORIBE K SHIBATA H KANAMARU A AKIYAMA Y GONDO H OKAMURA H ASANON S JUJI T SASAZUKI T TAKAKU F
Citation: Y. Kodera et al., ANALYSIS OF 313 TRANSPLANTATIONS FROM UNRELATED DONORS FACILITATED BYJAPAN MARROW DONOR PROGRAM, Experimental hematology, 24(9), 1996, pp. 665-665
A PHASE-II STUDY OF THE RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) FOLLOWING CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) CHEMOTHERAPY IN PATIENTSWITH SMALL-CELL LUNG-CANCER (SCLC)
Authors: KUDO S KURIHARA N FURUSE K KURITA Y FUKUOKA M TAKADA M TAKAKU F OGAWA M ARIYOSHI Y
Citation: S. Kudo et al., A PHASE-II STUDY OF THE RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) FOLLOWING CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) CHEMOTHERAPY IN PATIENTSWITH SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 31A, 1995, pp. 243-243
A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH THROMBOCYTOPENIA
Authors: ASANO S IKEDA Y TOYAMA K NOMURA T TAKAKU F
Citation: S. Asano et al., A PHASE-I TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH THROMBOCYTOPENIA, Blood, 86(10), 1995, pp. 2731-2731
A REVIEW OF 125 CASES TO DETERMINE THE RISK OF MYELODYSPLASIA AND LEUKEMIA IN PEDIATRIC NEUTROPENIC PATIENTS AFTER TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: IMASHUKU S HIBI S NAKAJIMA F MITSUI T YOKOYAMA S KOJIMA S MATSUYAMA T NAKAHATA T UEDA K TSUKIMOTO I HANAWA Y TAKAKU F
Citation: S. Imashuku et al., A REVIEW OF 125 CASES TO DETERMINE THE RISK OF MYELODYSPLASIA AND LEUKEMIA IN PEDIATRIC NEUTROPENIC PATIENTS AFTER TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR, Blood, 84(7), 1994, pp. 2380-2381
AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST-REMISSION
Authors: HARADA M KAWANO F SHIMAZAKI C SONODA Y OGAWA M TAKAKU F
Citation: M. Harada et al., AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST-REMISSION, British Journal of Haematology, 102(1), 1998, pp. 107-107
CAN THE COST OF ERYTHROPOIETIN FOR CARDIAC-SURGERY PATIENTS BE JUSTIFIED - REPLY
Authors: HAYASHI J KUMON K TAKANASHI S KAWASHIMA Y EGUCHI S TAKAKU F YAMAMURA H
Citation: J. Hayashi et al., CAN THE COST OF ERYTHROPOIETIN FOR CARDIAC-SURGERY PATIENTS BE JUSTIFIED - REPLY, Transfusion, 34(9), 1994, pp. 835-835
CD4(DULL -MARROW() HEMATOPOIETIC PROGENITOR CELLS IN MURINE BONE)
Authors: ONISHI M NAGAYOSHI K KITAMURA K HIRAI H TAKAKU F NAKAUCHI H
Citation: M. Onishi et al., CD4(DULL -MARROW() HEMATOPOIETIC PROGENITOR CELLS IN MURINE BONE), Blood, 81(12), 1993, pp. 3217-3225
CELL DENSITY-DEPENDENT APOPTOSIS IN HL-60 CELLS, WHICH IS MEDIATED BYAN UNKNOWN SOLUBLE FACTOR, IS INHIBITED BY TRANSFORMING-GROWTH-FACTORBETA-1 AND OVEREXPRESSION OF BCL-24
Authors: SAEKI K YUO A KATO M MIYAZONO K YAZAKI Y TAKAKU F
Citation: K. Saeki et al., CELL DENSITY-DEPENDENT APOPTOSIS IN HL-60 CELLS, WHICH IS MEDIATED BYAN UNKNOWN SOLUBLE FACTOR, IS INHIBITED BY TRANSFORMING-GROWTH-FACTORBETA-1 AND OVEREXPRESSION OF BCL-24, The Journal of biological chemistry, 272(32), 1997, pp. 20003-20010
CHARACTERIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY FILGRASTIM (RHUG-CSF) IN NORMAL VOLUNTEERS - DOSE-EFFECT RELATIONSHIP FOR FILGRASTIM WITH THE CHARACTER OF MOBILIZED PBPC
Authors: TANAKA R MATSUDAIRA T AIZAWA J EBIHARA Y MURAOKA K TSUJI K IKEBUCHI K KODAMA K TAKAKU F NAKAHATA T
Citation: R. Tanaka et al., CHARACTERIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY FILGRASTIM (RHUG-CSF) IN NORMAL VOLUNTEERS - DOSE-EFFECT RELATIONSHIP FOR FILGRASTIM WITH THE CHARACTER OF MOBILIZED PBPC, British Journal of Haematology, 92(4), 1996, pp. 795-803
CHARACTERIZATION OF ROOM-TEMPERATURE INDUCED APOPTOSIS IN HL-60
Authors: SHIMURA M ISHIZAKA Y YUO A HATAKE K OSHIMA M SASAKI T TAKAKU F
Citation: M. Shimura et al., CHARACTERIZATION OF ROOM-TEMPERATURE INDUCED APOPTOSIS IN HL-60, FEBS letters, 417(3), 1997, pp. 379-384
CLINICAL AND CYTOGENETIC FINDINGS OF MYELODYSPLASTIC SYNDROMES SHOWING HYPOCELLULAR BONE-MARROW OR MINIMAL DYSPLASIA, IN COMPARISON WITH TYPICAL MYELODYSPLASTIC SYNDROMES
Authors: TOYAMA K OHYASHIKI K YOSHIDA Y ABE T ASANO S HIRAI H HIRASHIMA K HOTTA T KURAMOTO A KURIYA S MIYAZAKI T KAKISHITA E MIZOGUCHI H MORI M SHIRAKAWA S TAKAKU F TOMONAGA M UCHINO H URABE A YASUNAGA K NOMURA T
Citation: K. Toyama et al., CLINICAL AND CYTOGENETIC FINDINGS OF MYELODYSPLASTIC SYNDROMES SHOWING HYPOCELLULAR BONE-MARROW OR MINIMAL DYSPLASIA, IN COMPARISON WITH TYPICAL MYELODYSPLASTIC SYNDROMES, International journal of hematology, 58(1-2), 1993, pp. 53-61
CLINICAL-APPLICATION OF CYTOKINES FOR CANCER-TREATMENT
Authors: TAKAKU F
Citation: F. Takaku, CLINICAL-APPLICATION OF CYTOKINES FOR CANCER-TREATMENT, Oncology, 51(2), 1994, pp. 123-128
CLINICAL EFFICACY OF FLUVASTATIN FOR HYPERLIPIDEMIA IN JAPANESE PATIENTS
Authors: TERAMOTO T GOTO Y KUROKAWA K NAKAMURA H YOSHIDA S SAITO Y NAKAYA N ITAKURA H TAKAKU F YAMADA N HATA Y KUZUYA F MABUCHI H KITA T TARUI S MATSUZAWA Y YAMAMOTO A TSUSHIMA M KAJIYAMA G ARAKAWA K ISHIOKA T
Citation: T. Teramoto et al., CLINICAL EFFICACY OF FLUVASTATIN FOR HYPERLIPIDEMIA IN JAPANESE PATIENTS, The American journal of cardiology, 76(2), 1995, pp. 33-36
CLINICAL IMPLICATIONS OF CHROMOSOMAL-ABNORMALITIES IN 401 PATIENTS WITH MYELODYSPLASTIC SYNDROMES - A MULTICENTRIC STUDY IN JAPAN
Authors: TOYAMA K OHYASHIKI K YOSHIDA Y ABE T ASANO S HIRAI H HIRASHIMA K HOTTA T KURAMOTO A KURIYA S MIYAZAKI T KAKISHITA E MIZOGUCHI H OKADA M SHIRAKAWA S TAKAKU F TOMONAGA M UCHINO H YASUNAGA K NOMURA T
Citation: K. Toyama et al., CLINICAL IMPLICATIONS OF CHROMOSOMAL-ABNORMALITIES IN 401 PATIENTS WITH MYELODYSPLASTIC SYNDROMES - A MULTICENTRIC STUDY IN JAPAN, Leukemia, 7(4), 1993, pp. 499-508
CYTOKINES AND BONE-MARROW TRANSPLANTATION
Authors: TAKAKU F
Citation: F. Takaku, CYTOKINES AND BONE-MARROW TRANSPLANTATION, Journal of cancer research and clinical oncology, 121(12), 1995, pp. 701-709
DETECTION OF THE PML RAR-ALPHA FUSION GENE IN ACUTE PROMYELOCYTIC LEUKEMIA WITH A COMPLEX TRANSLOCATION INVOLVING CHROMOSOME-15, CHROMOSOME-17, AND CHROMOSOME-18/
Authors: OGAWA S MITANI K SATO Y SUGIMOTO K TOYOSHIMA H MANO H TAKAKU F YAZAKI Y HIRAI H
Citation: S. Ogawa et al., DETECTION OF THE PML RAR-ALPHA FUSION GENE IN ACUTE PROMYELOCYTIC LEUKEMIA WITH A COMPLEX TRANSLOCATION INVOLVING CHROMOSOME-15, CHROMOSOME-17, AND CHROMOSOME-18/, Cancer genetics and cytogenetics, 69(2), 1993, pp. 113-117
Risultati: 1-25 | 26-50 | 51-61